Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotechnology company Compass Pathways plc (NASDAQ:CMPS) and Greenbrook TMS Inc (NASDAQ:GBNH) have entered into a three-year r...
A financial backer of the effort to legalize the drug MDMA for therapeutic use sees the potential for "exponential growth" should it win approval from the...
COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 4,350,000 shares, an increase of 12.7% from the November 30th total of 3,860,000 shares. Based on an average daily volume of 526,000 shares, the short-interest ratio […]
Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.
Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) have been assigned an average recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued a report on the […]